J. Thistlethwaite to Ganciclovir
This is a "connection" page, showing publications J. Thistlethwaite has written about Ganciclovir.
Connection Strength
0.043
-
Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial. Ann Intern Med. 1995 Jul 01; 123(1):18-26.
Score: 0.033
-
Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children. J Pediatr. 1997 Jul; 131(1 Pt 1):98-104.
Score: 0.010